Patients of autoimmune diseases at high risk of developing apical periodontitis

Written By : Dr. Shravani Dali |Medically Reviewed By : Dr. Kamal Kant Kohli Published On 2023-03-01T04:15:23+05:30 | Updated On 1 March 2023 1:40 PM IST

Patients of autoimmune diseases at high risk of developing apical periodontitis suggests a new study published in the International Endodontic Journal

The purpose of this case–control study was to compare the prevalence of apical periodontitis (AP) in patients affected by autoimmune disorders (AD) (inflammatory bowel disease [IBD], rheumatoid arthritis [RA] and psoriasis [Ps]) with the prevalence of AP in subjects without AD. The prevalences of AP in patients taking biologic medications, conventional medications and no medication were also compared.

Eighty-nine patients (2145 teeth) with AD were investigated and the control group included 89 patients (2329 teeth) with no systemic diseases. Full dental panoramic tomograms were used to determine the periapical status of the teeth. Additional variables investigated included patient's socio-demographic characteristics, medications taken by AD patients, the decayed, missing and filled teeth (DMFT) index. The chi-square test and logistic regression analysis were used to evaluate the correlation between AD and AP. p-Values lower than .05 were considered to be statistically significant.

Results

The prevalence of AP was 89.9% in AD patients and 74.2% in control subjects

The DMFT score was found to be significantly higher in the AD group

Patients with RA had the highest risk of being affected by AP, whereas those with IBD had the lowest risk. Multiple binary logistic regression analysis indicated that the teeth of AD patients who were not taking any medication or were being treated with biologic disease-modifying anti-rheumatic drugs (bDMARDs) had a higher risk of being affected by AP than did the teeth of the control subjects

The teeth of patients taking conventional DMARDs (cDMARDs) were less affected by AP compared with those of patients taking bDMARDs.

Patients with AD, whether treated or not with biologic medications, showed a higher prevalence of AP than did those in the control group. The DMFT index score, which was higher in AD patients compared with controls was identified as a significant predictor of AP prevalence.

Reference:

Allihaibi, M., Niazi, S.A., Farzadi, S., Austin, R., Ideo, F., Cotti, E. et al. (2023) Prevalence of apical periodontitis in patients with autoimmune diseases: A case-control study. International Endodontic Journal, 00, 1– 11. Available from: https://doi.org/10.1111/iej.13902

Keywords:

International Endodontic Journal, Patients, autoimmune, diseases, high risk, developing, apical periodontitis, Allihaibi, M., Niazi, S.A., Farzadi, S., Austin, R., Ideo, F., Cotti, E.

International Endodontic Journalpatientsautoimmunedisease interventionperiodontal pain

Source : International Endodontic Journal

Dr. Shravani Dali

Dr. Shravani Dali has completed her BDS from Pravara institute of medical sciences, loni. Following which she extensively worked in the healthcare sector for 2+ years. She has been actively involved in writing blogs in field of health and wellness. Currently she is pursuing her Masters of public health-health administration from Tata institute of social sciences. She can be contacted at editorial@medicaldialogues.in.

Dr. Kamal Kant Kohli

Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751